Investor Relations

Founded in 1991, AMRI provides scientific services, technologies and products that improve quality of life while delivering excellence, value and maximum return. AMRI's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing; and a separate, standalone R&D division comprising proprietary technologies, internal drug discovery and bundled capabilities designed for more collaborative relationships.

With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services and cost models.

View Investor Fact Sheet >>
View Investor Presentation >>

View 2010 Annual Report >>
View 2010 Proxy Statement >>